![19th Conference of the International Society of Geriatric Oncology](http://media.vumedi.com/thumbs/channel_logo/2019/10/a2aa5c30-39f1-4433-9e39-755b2936fd90.jpg.200x0_q85.jpg)
Hematologic Oncology
19th Conference of the International Society of Geriatric Oncology
Polypharmacy or Mobility Assessment in Patients With Haematological Malignancies: Polypharmacy Is Highly Prevalent and Prognostic, Impaired Mobility Is Prognostic, Medications May Impact Mobility
FEATURING
Tanya Wildes
- January 17, 2020
19th Conference of the International Society of Geriatric Oncology
AML in Older Adults: Should Intensive Therapy be Considered?
FEATURING
Heidi D. Klepin
- 49 views
- December 31, 2019